Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial-Reference-Cited by-同舟云学术

Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial

Published:1999-06 Issue:9169 Volume:353 Page:1993-2000
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Fisher Bernard,Dignam James,Wolmark Norman,Wickerham D Lawrence,Fisher Edwin R,Mamounas Eleftherios,Smith Roy,Begovic Mirsada,Dimitrov Nikolay V,Margolese Richard G,Kardinal Carl G,Kavanah Maureen T,Fehrenbacher Louis,Oishi Robert H

Publisher

Elsevier BV

Subject

General Medicine

Reference26 articles.

1. Noninvasive breast carcinoma: results of a national survey by the American College of Surgeons;Rosner;Ann Surg,1980

2. Duct carcinoma in situ: relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures;Lagios;Cancer,1982

3. Incidence of and treatment for ductal carcinoma in situ of the breast;Ernster;JAMA,1996

4. Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer;Fisher;N Eng J Med,1985

5. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer;Fisher;N Engl J Med,1993

Cited by 867 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update on the management of ductal carcinoma in situ of the breast: current approach and future perspectives;Japanese Journal of Clinical Oncology;2024-09-02

2. Endocrine therapy initiation among women diagnosed with ductal carcinoma in situ from 2001 to 2018;Breast Cancer Research and Treatment;2024-08-16

3. Re-Evaluating the Omission of Radiation Therapy in Low-Risk Patients With Early-Stage Breast Cancer;Clinical Breast Cancer;2024-07

4. Ductal carcinoma in situ of the breast: finding the balance between overtreatment and undertreatment;The Lancet;2024-06

5. Evaluation of the Efficacy of Postoperative Adjuvant Therapy for HER2-Positive Ductal Carcinoma in Situ with Microinvasion;Cancer Investigation;2024-05-24